SCHMC

Login 순천향대학교 부속 천안병원
검색

SCHMC Repository 진료부 내분비내과 1. Journal Papers

Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study

Metadata Downloads
Abstract
We aimed to assess the safety and efficacy of lobeglitazone in patients with type 2 diabetes over 52 weeks through 28-week extension study. Clinical benefits in terms of glycemic and lipid control were maintained for 52 weeks. Lobeglitazone showed a favorable balance of efficacy and safety during the extension study. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
All Author(s)
S. H. Kim ; S. G. Kim ; D. M. Kim ; J. T. Woo ; H. C. Jang ; C. H. Chung ; K. S. Ko ; J. H. Park ; Y. S. Park ; S. J. Kim ; D. S. Choi
Issued Date
2015
Type
Article
Keyword
Lobeglitazone; Thiazolidinediones; Clinical trial; Randomised trial
Publisher
International Diabetes Federation
Western Pacific Region of IDF
ISSN
0168-8227
Citation Title
Diabetes Research and Clinical Practice
Citation Volume
110
Citation Number
3
Citation Start Page
E27
Citation End Page
E30
Language(ISO)
eng
DOI
10.1016/j.diabres.2015.09.009
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/2265
Appears in Collections:
내분비내과 > 1. Journal Papers
공개 및 라이선스
  • 공개 구분공개
파일 목록

  • 관련 파일이 존재하지 않습니다.

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

SCHMC Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.